Skip to main content
Erschienen in: Supportive Care in Cancer 12/2013

01.12.2013 | Original Article

The Impact of Cancer Scale (IOC) in Italian long-term cancer survivors: adaptation and psychometric evaluation

verfasst von: Barbara Muzzatti, Cristiana Flaiban, Francesca Romito, Claudia Cormio, Maria Antonietta Annunziata

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The Impact of Cancer Scale (IOC) is a self-assessment tool designed to capture the unique and multidimensional aspects of the quality of life of long-term cancer survivors. This paper describes the adaptation and psychometric evaluation of its Italian version.

Methods

After the adaptation (i.e., removal of nonpertinent items and back-translation procedure), the Italian version of IOC has been administered to a sample of Italian long-term cancer survivors (people free from cancer and its treatments for at least 5 years) together with the Short Form 36 Health Survey Questionnaire, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, and the Post-Traumatic Growth Inventory.

Results

Data on 304 participants were analyzed. Exploratory factor analysis revealed a three-factor structure composed of Uncertainty/Worry about Health & Future (13 items), Personal Growth & Altruism (14 items), and Dissatisfaction & Life Interferences (10 items). Internal consistency (Cronbach's alpha, >0.77) and temporal stability (Spearman's rho, >0.70) were good for all three factors. The obtained three factors correlated with the theoretically pertinent subscales of the other administered tools. To facilitate cross-cultural comparisons, reliability and convergent/divergent validity data for the eight-factor IOC structure already described in literature (Impact of Cancer Version 2) have been also provided.

Conclusions

This study supports the use of the IOC in Italy as a trifactorial instrument that is able to isolate aspects characteristic of the condition of long-term cancer survivorship. However, subsequent studies are needed to confirm these findings as well as shed more light on the validity of the IOC construct and its cultural variability.
Literatur
1.
Zurück zum Zitat Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 suppl):2577–2592PubMedCrossRef Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 suppl):2577–2592PubMedCrossRef
2.
Zurück zum Zitat Foster C, Wright D, Hill H, Hopkinson J, Roffe L (2009) Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eu J Cancer Care (English) 18:223–247CrossRef Foster C, Wright D, Hill H, Hopkinson J, Roffe L (2009) Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eu J Cancer Care (English) 18:223–247CrossRef
3.
Zurück zum Zitat Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It's not over when it's over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It's not over when it's over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef
4.
Zurück zum Zitat Annunziata MA, Muzzatti B, Bianchet K, Berretta M, Chimienti E, Lleshi A, Tirelli U (2009) Sopravvivere al cancro: una rassegna sulla qualità di vita nella cancer survivorship. Psicologia della Salute 10:55–71 Annunziata MA, Muzzatti B, Bianchet K, Berretta M, Chimienti E, Lleshi A, Tirelli U (2009) Sopravvivere al cancro: una rassegna sulla qualità di vita nella cancer survivorship. Psicologia della Salute 10:55–71
5.
Zurück zum Zitat Tedeschi RG, Calhoun LG (1996) The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Traumatic Stress 9:455–472CrossRef Tedeschi RG, Calhoun LG (1996) The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Traumatic Stress 9:455–472CrossRef
6.
Zurück zum Zitat Pearce NJM, Sanson-Fisher R, Campbell HS (2008) Measuring quality of life in cancer survivors: a methodological review of existing scales. Psycho-Oncol 17:629–640CrossRef Pearce NJM, Sanson-Fisher R, Campbell HS (2008) Measuring quality of life in cancer survivors: a methodological review of existing scales. Psycho-Oncol 17:629–640CrossRef
7.
8.
Zurück zum Zitat Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L (2006) Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Oncol 15:407–421CrossRef Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L (2006) Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Oncol 15:407–421CrossRef
9.
Zurück zum Zitat Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the Impact of Cancer Scale. J Natl Cancer Inst 100:1530–1541PubMedCrossRef Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the Impact of Cancer Scale. J Natl Cancer Inst 100:1530–1541PubMedCrossRef
10.
Zurück zum Zitat Crespi CM, Smith SK, Petersen L, Zimmerman S, Ganz PA (2010) Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors. J Cancer Surviv 4:45–58PubMedCrossRef Crespi CM, Smith SK, Petersen L, Zimmerman S, Ganz PA (2010) Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors. J Cancer Surviv 4:45–58PubMedCrossRef
11.
Zurück zum Zitat Dahl HA, Gudbergsson SB, Dørum A, Fossa SD, Liavaag AH, Sørebø Ø (2012) The impact of cancer scale version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors. Qual Life Res 21(8):1459–1470PubMedCrossRef Dahl HA, Gudbergsson SB, Dørum A, Fossa SD, Liavaag AH, Sørebø Ø (2012) The impact of cancer scale version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors. Qual Life Res 21(8):1459–1470PubMedCrossRef
12.
Zurück zum Zitat Oerlemans S, Smith SK, Crespi CM, Zimmerman S, van de Poll-Franse LV, Ganz PA (2012) Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: a cross-national study. Psycho-Oncol. doi:10.1002/pon.3131 Oerlemans S, Smith SK, Crespi CM, Zimmerman S, van de Poll-Franse LV, Ganz PA (2012) Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: a cross-national study. Psycho-Oncol. doi:10.​1002/​pon.​3131
13.
Zurück zum Zitat Crespi CM, Ganz PA, Petersen L, Smith SK (2013) A procedure for obtaining Impact of Cancer version 2 scores using version 1 responses. Qual Life Res 22(1):103–109PubMedCrossRef Crespi CM, Ganz PA, Petersen L, Smith SK (2013) A procedure for obtaining Impact of Cancer version 2 scores using version 1 responses. Qual Life Res 22(1):103–109PubMedCrossRef
14.
Zurück zum Zitat Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432PubMedCrossRef Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432PubMedCrossRef
15.
Zurück zum Zitat Hahn EA, Bode RK, Du H, Cella D (2006) Evaluating linguistic equivalence of patient-reported outcomes in a cancer clinical trial. Clin Trials 3:280–290PubMedCrossRef Hahn EA, Bode RK, Du H, Cella D (2006) Evaluating linguistic equivalence of patient-reported outcomes in a cancer clinical trial. Clin Trials 3:280–290PubMedCrossRef
16.
Zurück zum Zitat Kazdin AE (1992) Research design in clinical psychology. Prentice Hall, New York Kazdin AE (1992) Research design in clinical psychology. Prentice Hall, New York
17.
Zurück zum Zitat Ware JE, Snow KK, Kosinki M, Gandek B (1993) SF-36 Health Survey—manual and interpretation guide. The Health Institute, Boston Ware JE, Snow KK, Kosinki M, Gandek B (1993) SF-36 Health Survey—manual and interpretation guide. The Health Institute, Boston
18.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
19.
Zurück zum Zitat Apolone G, Mosconi P, Ware JE (1997) Questionario sullo stato di salute SF-36, manuale d'uso e guida all'interpretazione dei risultati. Guerini e Associati, Milano Apolone G, Mosconi P, Ware JE (1997) Questionario sullo stato di salute SF-36, manuale d'uso e guida all'interpretazione dei risultati. Guerini e Associati, Milano
20.
Zurück zum Zitat Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P (1998) Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol 9:549–557PubMedCrossRef Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P (1998) Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol 9:549–557PubMedCrossRef
21.
22.
Zurück zum Zitat Cronbach L (1951) Coefficient alpha and the internal structure of test. Psychometrica 16:297–334CrossRef Cronbach L (1951) Coefficient alpha and the internal structure of test. Psychometrica 16:297–334CrossRef
23.
Zurück zum Zitat Burnand B, Kernan WN, Feinstein AR (1990) Indexes and boundaries for 'quantitative significance' in statistical decisions. J Clin Epidemiol 43:1273–1284PubMedCrossRef Burnand B, Kernan WN, Feinstein AR (1990) Indexes and boundaries for 'quantitative significance' in statistical decisions. J Clin Epidemiol 43:1273–1284PubMedCrossRef
24.
Zurück zum Zitat Bartlett MS (1954) A note on multiplying factors for various chi-square approximations. J Royal Statist Soc 16:296–298 Bartlett MS (1954) A note on multiplying factors for various chi-square approximations. J Royal Statist Soc 16:296–298
25.
Zurück zum Zitat Kaiser H (1974) An index of factorial simplicity. Psychometrika 39:31–36CrossRef Kaiser H (1974) An index of factorial simplicity. Psychometrika 39:31–36CrossRef
Metadaten
Titel
The Impact of Cancer Scale (IOC) in Italian long-term cancer survivors: adaptation and psychometric evaluation
verfasst von
Barbara Muzzatti
Cristiana Flaiban
Francesca Romito
Claudia Cormio
Maria Antonietta Annunziata
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1909-1

Weitere Artikel der Ausgabe 12/2013

Supportive Care in Cancer 12/2013 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.